Publications by authors named "Boris V Nikonenko"

Claim this Profile
I
Indole triazene compound TU112 demonstrates in vitro activity against dormant Mycobacterium tuberculosis and efficacy against chronic tuberculosis infection in mice.
Margarita O Shleeva, Boris V Nikonenko, Konstantin B Majorov, Pavel Yu Ivanov, Alexander S Apt

Tuberculosis (Edinb)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Modifications of 3-Triazeneindoles and Their Increased Activity Against .
Konstantin B Majorov, Boris V Nikonenko, Pavel Yu Ivanov, Lyudmila N Telegina, Alexander S Apt

Antibiotics (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.
Tatiana K Kondratieva, Marina A Kapina, Elvira I Rubakova, Elena V Kondratieva, Boris V Nikonenko

Tuberculosis (Edinb)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
Boris V Nikonenko, Albert Kornienko, Konstantin Majorov, Pavel Ivanov, Tatiana Kondratieva

Antimicrob Agents Chemother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug testing in mouse models of tuberculosis and nontuberculous mycobacterial infections.
Boris V Nikonenko, Alexander S Apt

Tuberculosis (Edinb)· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tuberculosis drug therapy in mice of different inbred strains.
Boris V Nikonenko, Leo Einck, Carol A Nacy

Infect Genet Evol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis.
Boris V Nikonenko, Venkata M Reddy, Marina Protopopova, Elena Bogatcheva, Leo Einck

Antimicrob Agents Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical study of new TB drugs and drug combinations in mouse models.
Boris V Nikonenko, Katherine A Sacksteder, Sam Hundert, Leo Einck, Carol A Nacy

Recent Pat Antiinfect Drug Discov· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs.
Boris V Nikonenko, Marina Protopopova, Rowena Samala, Leo Einck, Carol A Nacy

Antimicrob Agents Chemother· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis.
Boris V Nikonenko, Rowena Samala, Leo Einck, Carol A Nacy

Antimicrob Agents Chemother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice.
Fabio Sánchez, Tatiana V Radaeva, Boris V Nikonenko, Ann-Sophie Persson, Selim Sengul

Infect Immun· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine Model of Tuberculosis. In vitro and in vivo Study.
Boris V Nikonenko, Colleen Hanrahan

Russ J Immunol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis